Biotech Competitive Intelligence Across Trials, Patents, Literature and Market Signal
Build competitive landscapes, TPP comparisons, patent-cliff views, market-share scenarios, and response plans from live web, trial, patent, literature, and database evidence.
Decision questions
What this solution is built to answer.
Who is ahead, behind, crowded, underfunded, or exposed?
What trial, patent, literature, funding, and company signals change the competitive field?
Which competitor actions require a response plan?
Where are the white-space and timing advantages?
Science and method
What can change the model or gate.
Quickscan, deep-dive, and war-room workflow tiers.
TPP benchmarking and radar-style comparison outputs.
Patent-cliff and loss-of-exclusivity timing analysis.
Pipeline-density, sponsor-distribution, positioning, and scenario visuals.
Separate lanes for web, trials, patents, literature, grants, valuation, and coding.
Method and decision gates
How the case is computed and reviewed.
| Workflow | Role | Artifacts |
|---|---|---|
| competitive-landscape-quickscan | Top-line market and asset map | Fast landscape summary and open questions |
| competitive-landscape-deepdive | Evidence-grade field judgment | TPP radar, patent cliff, profiles, market-share scenarios |
| competitive-landscape-warroom | Response planning | Launch defense, competitor-move scenarios, action plan |
Evidence inputs
Supporting evidence, rights and decision inputs.
Decision record
What remains available for review.
Deliverables
Competitor matrix with evidence trail.
TPP comparison visuals.
Patent timing and loss-of-exclusivity exhibits.
Strategic response memo or committee landscape report.
Proof points
The deep-dive workflow bundles dedicated scripts for TPP radar and patent-cliff visuals.
The system has separate patent, web, literature, trial, grant, valuation, and coding specialists.
Evidence files are produced before synthesis so the final report can be challenged.
Limits and review conditions
What this result does not establish.
Monitoring distinguishes observed facts from interpretation. A missed, delayed or inaccessible disclosure remains possible.
FAQ
Common evaluation questions.
What makes this different from a web search summary?
The work is split into evidence lanes and returned as files, tables, visuals, and findings that can be inspected before synthesis.
Can ARiDA track recent competitor changes?
Yes. Trial monitoring, live web acquisition, and scheduled background workflows are built into the platform model.
Related solutions
Clinical Trial Intelligence
Analyze trial landscapes, protocol patterns, endpoints, enrollment signals, sponsor behavior, recent registry changes, and historical AACT structure.
Patent Landscape
Map biotech patent families, assignees, citations, jurisdictions, claims, and whitespace using EPO, Google Patents data, web extraction, and structured IP workflows.
Systematic Review
Run PRISMA-style biomedical literature reviews with PubMed and PMC search lanes, screening logic, evidence tables, certainty summaries, and durable review artifacts.
Related reading
Run a competitive landscape around a decision, not a company list
A useful landscape explains which competitor changes the target profile, timing or investment case.
The missing layer between scientific systems and business models
Biopharma teams still move critical assumptions by hand between evidence tools and financial models.
Combine scientific data and code without erasing provenance
Acquisition, normalization and computation need separate records inside the same decision case.